Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Nike
NKE
|
+$631M |
| 2 |
PNC Financial Services
PNC
|
+$614M |
| 3 |
XYZ
Block, Inc.
XYZ
|
+$328M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$275M |
| 5 |
FedEx
FDX
|
+$236M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Meta Platforms (Facebook)
META
|
+$595M |
| 3 |
AbbVie
ABBV
|
+$489M |
| 4 |
Crown Castle
CCI
|
+$326M |
| 5 |
McDonald's
MCD
|
+$325M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 16.57% |
| 3 | Financials | 13.84% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
451
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10.5M | 0.01% |
683,906
+9,768
| +1% | +$149K |
|
452
Wheaton Precious Metals
WPM
$48.7B
| $10.4M | 0.01% |
509,171
-210,760
| -29% | -$4.29M |
|
453
Sunrun
RUN
$3.69B
| $9.99M | 0.01% |
1,118,189
+151,485
| +16% | +$1.35M |
|
454
REV Group
REVG
$3.12B
| $9.97M | 0.01% |
480,416
+406,493
| +550% | +$8.44M |
|
|
FMI
455
DELISTED
Foundation Medicine, Inc.
FMI
| $9.85M | 0.01% |
+125,096
| New | +$9.85M |
|
456
B&G Foods
BGS
$369M
| $9.85M | 0.01% |
415,540
+2,567
| +0.6% | +$60.8K |
|
457
Corning
GLW
$64.6B
| $9.78M | 0.01% |
350,917
-11,140,517
| -97% | -$311M |
|
458
Cogent Biosciences
COGT
$1.79B
| $9.78M | 0.01% |
+224,189
| New | +$9.78M |
|
|
BPL
459
DELISTED
Buckeye Partners, L.P.
BPL
| $9.6M | 0.01% |
256,626
-14
| -0% | -$523 |
|
|
PSDO
460
DELISTED
Presidio, Inc. Common Stock
PSDO
| $9.51M | 0.01% |
607,975
-503,183
| -45% | -$7.87M |
|
461
WSFS Financial
WSFS
$3.17B
| $9.2M | 0.01% |
192,003
+227
| +0.1% | +$10.9K |
|
462
ProQR Therapeutics
PRQR
$231M
| $9.07M | 0.01% |
2,950,374
+314,822
| +12% | +$968K |
|
463
HealthEquity
HQY
$7.96B
| $8.74M | 0.01% |
144,391
+4,119
| +3% | +$249K |
|
464
Apellis Pharmaceuticals
APLS
$3.21B
| $8.38M | 0.01% |
379,151
-227,774
| -38% | -$5.04M |
|
465
Clearway Energy Class A
CWEN.A
$3.21B
| $8.33M | 0.01% |
506,606
| – | – |
|
|
NSU
466
DELISTED
Nevsun Resources Ltd.
NSU
| $7.9M | 0.01% |
3,314,592
-1,000,083
| -23% | -$2.38M |
|
467
Adicet Bio
ACET
$73.4M
| $7.81M | 0.01% |
+116,508
| New | +$7.81M |
|
468
Vital Energy
VTLE
$649M
| $7.65M | 0.01% |
43,927
-57,457
| -57% | -$10M |
|
469
NCS Multistage Holdings
NCSM
$123M
| $7.53M | 0.01% |
25,109
-8,032
| -24% | -$2.41M |
|
470
Savara
SVRA
$620M
| $7.21M | 0.01% |
783,622
+67,952
| +9% | +$625K |
|
471
Select Water Solutions
WTTR
$954M
| $7.11M | 0.01% |
563,376
+136,277
| +32% | +$1.72M |
|
472
iRhythm Technologies
IRTC
$5.82B
| $7.05M | 0.01% |
112,037
+15,621
| +16% | +$983K |
|
473
Atara Biotherapeutics
ATRA
$85.4M
| $7.05M | 0.01% |
+7,228
| New | +$7.05M |
|
474
Kinross Gold
KGC
$28.3B
| $6.67M | 0.01% |
1,688,214
-461,705
| -21% | -$1.82M |
|
|
ICD
475
DELISTED
Independence Contract Drilling, Inc.
ICD
| $6.65M | 0.01% |
87,963
-16,066
| -15% | -$1.21M |
|